Login or e-mail Password   

Ebola - How Great is This Threat and How is IT Managed

Ebola is a highly deadly infectious disease and it is very contagious by near contact. It can however easily be confined to restricted areas.
Views: 635 Created 08/24/2014

Ebola is a contagious viral disease that attacks the digestive system from the mouth to anus, the kidneys, the circulatory system, the liver and in less severe degree the skin, eyes, nose and ears, resulting in multiple organ failure.

The disease is 40-60% lethal with treatment and near 100% lethal without treatment. It appears to be a new disease, at least among humans, discovered first in areas of Zaire in 1976. Up to now there has been several outbreaks of the disease, most of them in restricted areas in Western Africa. Around 1850 persons have been attacked by mid 2014, of which 1200 died.

The disease is caused by a group of several similar viruses, called Ebolavirus, in the family Filoviridae of the order Mononegavirales. The viruses are shaped like tubes, sometimes branched tubes, and use single-stranded RNA as material for genetic coding. Therefore the infected cells are commanded to make a corresponding DNA copy by means of the enzyme reverse transcriptase. The DNA copy is used by the infected cell for the production of viral protein and new viral RNA.

The virus spreads from person to person by exchange of blood, corporeal fluids and other materials from the body. It can also spread with animals that transmit body material through biting, for example by fruit bats. The virus does not spread easily through air at a long distance from one human to another. It is however very contagious by close human contact, and medical personal will be in great danger without using unpermeable clothes and filtration of the air they breath.

An epidemic usually begins when a human comes in touch with body fluids, body parts or body products like feces or urine from an infected animal, or is bitten by an infected animal, most commonly a monkey, a chimp, a pig or a fruit bat. The disease seems to be permanently present in populations of these animals without making the animals severely ill.

During epidemies in 2014 the disease has spread more rapidly out of traditional restricted zones to wider areas in Western Africa. This might indicate new strains of the virus capable of more rapid transmission or a spread of animals that carry the virus.

The incubation period varies from two days to three weeks. In that period the disease is little contagious. The disease then suddenly begins with high fever, sore throat, lethargy, muscle and joint ache and severe headache.

Later there will be nausea, stomach pain, diarrhea, vomiting, swallowing problems and elevated rashes. The function of the liver, kidneys and circulatory system can suffer gravely due to tissue death, inner bleeding, blood coagulation, and disturbances in the distribution of body fluids. The blood pressure can fall dangerously. Patient will often bleed from the eyes. Also tissue destruction and bleeding inside the skin can occur.

In severe cases near death more extensive tissue destruction inside body cavities can occur, resulting in bleeding from the ears, the nose, in the mouth and through the rectum.  The death is caused by simultaneous failure of several organs. As the disease proceed, it results in severe weight loss and weakness, and the reconvalescent period is long.

Early symptoms of the disease can resemble many other feverish diseases with bleedings, like typhoid or malaria. For a secure diagnosis one tests immunological reactions and the presence of enzymes linked to the viral infection in blood samples.

There is no vaccine against the virus and until 2014 there was no treatment directly against the viral infection. By the summer 2014 the treatment regimes against the virus itself are so far experimental and not yet proven to work well, but are tried out in actual cases. Vaccines are being developed. Up until 2014 treatment consists solely of supporting the body with oxygen,  fluid, electrolytes, nourishment, circulation support, blood transfusion and other types of support as long as the infection is active and in the reconvalescent period.

Infected patients are isolated and populations that house infected individuals are also isolated by restriction entering and leaving the afflicted area. Medical personal and support staff that go near to the patients use unpermeable clothes around themselves and all the air they breath is filtered. In advanced treatment settings, the patient is shielded from the surroundings with unpenetrable barriers and air filters.

------------------------------------------------------------------------------

Knut Holt is a business consultant and marketer focusing on the health field. At his site there are more information about health and fitness. You can also find presentation of products to improve health, and of products in the categories hobby, automotive and apparel.

http://www.abicana.com/health_information.htm

This article is free to copy as long as the author's name and link is present.

Similar articles


11
comments: 8 | views: 8890
9
comments: 0 | views: 4598
9
comments: 14 | views: 27241
9
comments: 3 | views: 3682
8
comments: 10 | views: 7555
8
comments: 2 | views: 23755
8
comments: 13 | views: 45853
8
comments: 3 | views: 12594
7
comments: 11 | views: 5446
7
comments: 14 | views: 15072
 
Author
Article

Related topics






No messages


Add your opinion
You must be logged in to write a comment. If you're not a registered member, please register. It takes only few seconds, and you get an access to additional functions .
 


About EIOBA
Articles
Explore
Publish
Community
Statistics
Users online: 152
Registered: 107.587
Comments: 1.491
Articles: 7.165
© 2005-2018 EIOBA group.